Earth Science Tech Inc. (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, has completed the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products. The acquisition is a strategic move to broaden the company's telehealth and pharmacy fulfillment platforms into complementary verticals, according to a press release.
Zoolzy, based in Doral, Florida, operates from a 3,684-square-foot facility and specializes in the distribution of APIs and finished FDA-approved prescription products (https://ibn.fm/vcqkE). The acquisition supports ETST's compounding pharmacies by enabling them to secure essential raw materials at highly competitive wholesale pricing, significantly increasing the company's overall profit margins.
The acquisition delivers value across three growth drivers: expanding overall profit margins, broadening access to new ingredients, and enabling entry into the veterinary market. By integrating Zoolzy's distribution capabilities, ETST can leverage its existing infrastructure to enhance its supply chain and reduce costs, which is critical in the competitive pharmaceutical landscape.
ETST's move reflects its strategy to seize opportunities that diversify its offerings and strengthen its market position. The company, which focuses on healthcare, pharmacy, and telemedicine, aims to capitalize on the growing demand for APIs and finished pharmaceuticals, particularly in niche markets such as veterinary medicine.
The acquisition also aligns with ETST's broader vision of creating a vertically integrated healthcare platform. By controlling the supply of essential ingredients, ETST can ensure quality and consistency in its compounded medications, which is vital for patient safety and regulatory compliance.
For more information on Earth Science Tech and its latest developments, visit the company's newsroom at https://ibn.fm/ETST.
